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Summary
 
Acute infections with viruses such as lymphocytic choriomeningitis virus (LCMV) are associ-
ated with a massive polyclonal T cell response, but the specificities of only a small percentage of
these activated T cells are known. To determine if bystander stimulation of T cells not specific
to the virus plays a role in this T cell response, we examined two different systems, HY-specific
T cell receptor (TCR)-transgenic mice, which have a restricted TCR repertoire, and LCMV-
carrier mice, which are tolerant to LCMV. LCMV infection of HY-transgenic C57BL/6 mice
induced antiviral CTLs that lysed target cells coated with two of the three immunodominant
epitopes previously defined for LCMV (glycoprotein 33 and nucleoprotein 397). Although
LCMV-induced cytotoxic T lymphocytes (CTLs) from C57BL/6 mice could lyse uninfected
H-2
 
k
 
 and H-2
 
d
 
 allogeneic targets, LCMV-induced CTLs from HY mice lysed only the H-2
 
k
 
-
expressing cells. The HY mice generated both anti-H-2
 
k
 
 and anti-H-2
 
d
 
 CTL in mixed leuko-
cyte reactions, providing evidence that the generation of allospecific CTLs during acute
LCMV infection is antigen specific. During the LCMV infection there was blastogenesis of the
CD8
 
1
 
 T cell population, but the HY-specific T cells (as determined by expression of the
TCR-
 
a
 
 chain) remained small in size. To examine the potential for bystander stimulation un-
der conditions of a very strong CTL response, T cell chimeras were made between normal and
HY mice. Even in the context of a normal virus-induced CTL response, no stimulation of
HY-specific T cells was observed, and HY-specific cells were diluted in number by day 9 after
infection. In LCMV-carrier mice in which donor and host T cells could be distinguished by
Thy1 allotypic markers, adoptive transfer of LCMV-immune T cells into LCMV-carrier mice,
whose T cells were tolerant to LCMV, resulted in activation and proliferation of donor CD8
cells, but little or no activation of host CD8 cells. These results support the hypothesis that the
massive polyclonal CTL response to LCMV infection is virus-specific and that bystander acti-
vation of non–virus-specific T cells is not a significant component of this response.
 
D
 
uring the course of a viral infection there are pro-
found physiological changes that take place as the im-
munocompetent host mounts an immune response to the
invading pathogen. These responses include activation of
the cellular and humoral arms of the immune system. A
useful model system for studying the activation and func-
tion of CD8
 
1
 
 T lymphocytes has been lymphocytic chorio-
meningitis virus (LCMV)
 
1
 
 infection. Upon infection of
C57BL/6 mice with LCMV, there is a massive 5–20-fold
expansion of the number of CD8
 
1
 
 lymphocytes in the
spleen (1–3). The majority of these cells express activation
markers such as CD44 (4), IL-2R (CD25; 5), and the adhe-
sion molecule Mac-1 (6). By day 6 after infection many
CD8
 
1
 
 cells are blast sized (7), and by day 8, 25% of the
splenic T cells contain clearly defined azurophilic cytoplas-
mic granules containing perforin and serine esterases, indic-
ative of a highly activated T cell population (8, 9).
This highly activated CD8
 
1
 
 T cell population not only
contains CTLs capable of lysing virus-infected targets, but
also contains T cells that will lyse various uninfected alloge-
neic targets (3). Many T cell clones isolated during the
acute LCMV infection and propagated on virus-infected
APCs lyse uninfected allogeneic targets, and some of these
lyse the allogeneic target much better than the virus-infected
syngeneic target (1). This suggests that the T cell response
to viral infections consists of T cells with a wide array of af-
finities and specificities. Infection of LCMV-immune mice
with heterologous viruses such as vaccinia virus (VV),
Pichinde virus (PV), or murine cytomegalovirus (MCMV)
 
1
 
Abbreviations used in this paper:
 
 FSC, forward scatter; GP, glycoprotein;
LCMV, lymphocytic choriomeningitis virus; LDA, limiting dilution anal-
ysis; LU, lytic units; MCMV, murine cytomegalovirus; pCTL, precursor
CTL; poly I:C, poly inosinic:cytidylic acid; NP, nucleoprotein; PV,
Pichinde virus; VV, vaccinia virus.
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reactivated LCMV-specific memory CTL (3, 10), as shown
by direct bulk CTL assays ex vivo. Surprisingly, clonal
CTL assays showed that these heterologous virus infections
could reactivate memory CTLs cross-reactive between the
two viruses. This indicates that memory cell reactivation
could also contribute to the virus-induced polyclonal T cell
activation.
Using bulk CTL assays and limiting dilution analyses
(LDAs), however, we have only been able to account for
the specificities of between 5–10% of these activated CD8
 
1
 
lymphocytes. LCMV encodes no known superantigen, and
the explanation for this profound expansion in the numbers
of CD8
 
1
 
 T cells remains unresolved. One mechanism
could be that many of these T cells are not virus-specific,
but are activated via bystander stimulation due to the large
concentration of cytokines that are present during the acute
phase of an LCMV infection. Another possibility is that
these cells are activated through their TCRs, which react
with LCMV-peptide–MHC complexes on the surface of
virus-infected cells. Many of these T cells, however, would
probably be of low affinity, and would not be detected in
bulk or even in clonal cytotoxicity assays, but would be ac-
tivated in vivo due to the plethora of antigens and cytokines
present during acute infection. To determine whether viral
antigen-independent bystander stimulation of non–cross-
reactive T cells was occurring, we examined the CD8
 
1
 
 T
cell response to LCMV infection in the HY-specific TCR-
transgenic mouse (11) and in persistently infected normal
mice whose T cells are tolerant to LCMV.
There are two useful attributes of the T cell compart-
ment of the HY mouse. The first trait is that all T cells in
the HY mouse express a single, transgenic V
 
b
 
8.2-contain-
ing TCR chain. As a result, these animals have a restricted
T cell repertoire in which all immune responses must be
orchestrated in the context of a single TCR-
 
b
 
 chain. The
second feature is that between one-third and one-half of
the CD8 T cells also express the transgenic V
 
a
 
3 chain.
Dual expression of these two transgenic TCRs imparts
upon the T cell specificity for the male-specific HY antigen
in the context of H-2D
 
b
 
. These HY-specific T cells can be
distinguished from the rest of the CD8
 
1
 
 T cells by the
monoclonal antibody T3.70, which detects a clonotypic
determinant on the transgenic 
 
a
 
 chain (12). Using these
particular characteristics of the HY transgenic mouse, we
analyzed the kinetics and specificities of the antiviral T cell
response and examined the fate of the non–LCMV-reac-
tive HY-specific T cells during virus infection.
To look for the bystander activation of a more conven-
tional nontransgenic T cell population containing both na-
ive and memory T cells, we made use of LCMV-carrier
mice. This was a system in which we could distinguish
memory and naive host cells from memory donor cells that
were responding to the antigen in the LCMV-carrier mice.
Using these congenic mice, we observed that despite a vig-
orous immune response carried out by the donor cells, the
host CD8 T cells did not increase in size or number and
did not change expression of activation markers. Together
these systems indicate that bystander activation of non–
virus-specific T cells contributes little to the increase in T
cell number during virus infections.
 
Materials and Methods
 
Mice. 
 
Conventionally housed male and female C57BL/6
(H-2
 
b
 
; Thy1.2), B6.PL Thy1
 
a
 
/Cy (H-2
 
b
 
; Thy1.1), and LCMV-
carrier C57BL/6 mice were either purchased from Jackson Labs.
(Bar Harbor, ME) or bred in the Department of Animal Medi-
cine at the University of Massachusetts Medical Center (Worces-
ter, MA). C57BL/6 HY-transgenic mice, whose transgenic TCR
is specific for the male antigen HY in the context of H-2D
 
b
 
, were
provided by B.J. Fowlkes (National Institutes of Health, Be-
thesda, MD). HY-transgenic and (C57BL/6 
 
3
 
 bm12)F1 mice
were bred and maintained in the Department of Animal Medi-
cine at the University of Massachusetts Medical Center under mi-
croisolator conditions. Transgenic mice were typed using anti-
CD8-PE (GIBCO BRL, Gaithersburg, MD) and anti-V
 
b
 
8.1/8.2
FITC (PharMingen, San Diego, CA) to stain PBLs obtained via
blood drawn from the retro-orbital sinus.
 
Cells and Virus. 
 
MC57G (H-2
 
b
 
), a methylcholanthrene-induced
fibroblast cell line from C57BL/6 mice, and vero cells were prop-
agated in MEM (GIBCO BRL) supplemented with 100 U/ml of
penicillin G, 100 
 
m
 
g/ml streptomycin sulfate, 2 mM 
 
l
 
-glutamine,
10 mM Hepes (United States Biochemical Corp., Cleveland,
OH), and 10% heat-inactivated (56
 
8
 
C, 30 min) fetal bovine serum
(FBS; Sigma Chemical Co., St. Louis, MO). The TAP-2–deficient
cell line RMA-S was from Hans-Gustaff Ljunggren (Karolinska
Institute, Stockholm, Sweden) and was grown in RPMI-1640,
supplemented as above. The LCMV Armstrong strain was propa-
gated in baby hamster kidney BHK21 cells. Mice were injected
intraperitoneally with 4 
 
3
 
 10
 
4
 
 PFU of virus unless otherwise in-
dicated. PV was propagated as described by Yang et al. (3). Spleens
from infected mice were homogenized and titrated for virus by
plaque assay on vero cell monolayers.
 
Spleen Cell Preparation and Cytotoxicity Assays. 
 
Spleen cell sus-
pensions were depleted of erythrocytes by briefly suspending the
cell pellet in a 0.84% NH
 
4
 
Cl solution before rinsing. Cell-medi-
ated cytotoxicity was determined using a standard microcytotox-
icity assay (13). In brief, target cells were pelleted and resus-
pended in 100 
 
m
 
Ci of Na
 
51
 
Cr (Amersham Corp., Arlington
Heights, IL) per 10
 
6
 
 cells and incubated at 37
 
8
 
C in a humidified
5% CO
 
2
 
 incubator for 1 h. Varying numbers of effector cells were
added in 0.1-ml volumes to achieve the desired E/T ratios. For a
spontaneous 
 
51
 
Cr-release control, 0.1 ml of complete MEM was
substituted for effector cells. Maximum release was determined by
adding 0.1 ml of 1% Nonidet P-40 to the well. After 6 h at 37
 
8
 
C,
the plates were centrifuged at 200 
 
g
 
 for 5 min, and 0.1 ml of su-
pernatant was removed from each well and counted on a gamma
counter (model 5000; Beckman Instrs., Inc., Palo Alto, CA).
Data were presented as percent specific 
 
51
 
Cr-release 
 
5
 
 100 
 
3
 
([experimental cpm 
 
2
 
 spontaneous cpm] / [maximum release cpm
 
2
 
 spontaneous cpm]). Limiting dilution assays to determine the
precursor frequencies for LCMV-specific CTL were performed
using the procedure of Selin et al. (10), and frequencies were cal-
culated using 
 
x
 
2
 
 analysis according to Taswell (14) on a computer
program provided by R. Miller (University of Michigan, Ann
Arbor, MI). For mixed lymphocyte cultures, varying numbers of
spleen cells from female C57BL/6 mice or female HY-transgenic
mice were co-cultured with 2 
 
3
 
 10
 
5
 
 female irradiated (3,000
Rad) allogeneic spleen cells in the presence of 5 Cetus units of re-
combinant human IL-2/ml. After 4 d the cultures were tested for 
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cytotoxic activity against syngeneic and allogeneic targets in a
standard CTL assay.
 
Detection of Transgenic T Cells. 
 
Spleen cells were prepared as
stated above, and 10
 
6
 
 cells were incubated with normal mouse se-
rum for 20 min at 4
 
8
 
C. The cells were then incubated with the
biotin-labeled monoclonal antibody T3.70 (a gift from H. Teh,
University of British Columbia, Vancouver, Canada) for 30 min
on ice. The cells were then washed twice and blocked again with
normal mouse serum at 4
 
8
 
C for 20 min. Next, the cells were
stained with anti-CD8-PE (GIBCO BRL) and streptavidin-FITC
(Becton Dickinson, San Jose, CA) for 25 min at 4
 
8
 
C. The cells
were then washed twice and fixed with 2% paraformaldehyde. Af-
ter staining, cells were analyzed or sorted by flow cytometry using
a FACSTAR
 
Ò
 
. Data analysis was performed using the program
PC-LYSIS (Becton Dickinson).
 
Adoptive Transfer of Immune Spleen Cells into LCMV-carrier Mice.
 
A total of 2–4 
 
3
 
 10
 
7
 
 spleen cells from LCMV-immune B6.PL
Thy1
 
a
 
/Cy mice (Thy1.1
 
1
 
) were injected intravenously via the
retro-orbital sinus into C57BL/6 LCMV-carrier mice (Thy1.2
 
1
 
).
Spleens were harvested at various days after transfer and evaluated
by flow cytometry.
 
Results
 
Antiviral Response in HY-transgenic Animals. 
 
To study the
specificity and magnitude of the antiviral CD8
 
1
 
 T cell re-
sponse in the HY-transgenic mice, we first questioned
whether the restrictions on the T cell repertoire would
prevent a virus-specific T cell response from taking place.
We therefore chose first to examine if the HY-transgenic
animals were capable of clearing infectious virus from the
spleen and how this compared to viral clearance in wild-
type animals. As shown in Table 1, HY-transgenic animals
and normal female C57BL/6 mice had similar viral titers 4 d
after infection, but thereafter, HY-transgenic animals cleared
LCMV with delayed kinetics when compared to normal
mice. These observations are complementary to those of Ew-
ing et al. (15) who showed that transgenic mice expressing
only a single, randomly selected TCR-
 
b
 
 chain could clear
influenza A virus from their lungs, but did so with delayed
kinetics. This delay in kinetics may reflect the reduced
number of LCMV-specific precursor CTLs present in this
animal due to the restricted TCR repertoire (see below).
We next examined the magnitude of the in vivo antiviral
CTL response mounted by the HY-transgenic mice. Using
standard ex vivo CTL assays, it was observed that at 8 d af-
ter LCMV infection, when C57BL/6 animals displayed
high levels of CTL activity, the HY animals displayed a
more modest level of cytotoxicity (Fig. 1). Using lytic units
(LU; calculated at 35% lysis) to evaluate the differences in
the levels of CTL activity between these two populations,
we found in four different experiments that wild-type ani-
mals had 5.5 
 
6
 
 1.3 LU/10
 
6
 
 spleen cells, whereas HY-
transgenic mice had only 1.0 
 
6
 
 0.4 LU/10
 
6
 
 spleen cells.
The LU calculated for the HY mice, however, also include
the higher levels of lysis of uninfected syngeneic cells (see
Fig. 1) and are probably an overestimation of the virus-spe-
cific CTL activity. These observations are consistent with
the experiments performed by Doherty et al. that showed
that transgenic CBA/Ca mice expressing only a single ran-
domly selected TCR-
 
b
 
 chain had lower CTL activity after
LCMV infection than did wild-type mice (16) and those of
Woodland et al., where it was observed that a large dele-
tion in the TCR-
 
b
 
 chain locus of BALB/c mice resulted in
a reduction in the response to many common antigens (17).
The higher levels of background killing observed with
lymphocytes from the transgenic mice against uninfected
syngeneic MC57G (H-2
 
b
 
) targets were probably due to
NK cells, which would likely undergo a period of pro-
longed activation in these animals due to the fact that the
virus persisted in the spleen for a longer duration than in
the wild-type C57BL/6 mice (Table 1). Consistent with
this hypothesis, an anti-CD8 antibody that inhibited CTL-
mediated killing failed to inhibit the lysis of uninfected
MC57G cells, and in vivo administration of antibodies to
the NK cell marker asialo GM
 
1
 
 reduced this killing (data
not shown).
 
Precursor CTL Frequencies in LCMV-immune HY-transgenic
Mice. 
 
To determine whether the relatively modest CTL
response during acute infection of HY mice was also subse-
quently reflected in the memory response, we performed
LDAs to determine the number of precursor CTLs (pCTLs)
present in LCMV-immune mice. It has been shown that
the number of LCMV-specific pCTL remains fairly con-
stant for over a year after infection and that this memory
 
Table 1.
 
Kinetics of Viral Clearance from Normal and
Transgenic Mice
 
Days after infection
Log
 
10
 
 PFU/spleen
 
*
 
C57BL/6 mice HY mice
4 5.1 
 
6
 
 0.3 5.4 
 
6
 
 0.2
7
 
,
 
2.1
 
‡
 
3.1 
 
6
 
 0.2
8
 
,
 
2.0 2.9 
 
6
 
 0.3
9
 
,
 
2.0
 
,
 
2.2
 
‡
 
*
 
n
 
 
 
5
 
 3/group.
 
‡
 
Only one of three animals had any detectable virus.
Figure 1. Direct CTL activity
mediated by spleen leukocytes 8 d
after LCMV infection of C57BL/6
mice and HY-transgenic mice.
Spleen cells were prepared as
stated in Materials and Methods
and tested against 51Cr-labeled
MC57G cells. Circles represent
specific lysis by a single wild-
type (open circle) and HY-trans-
genic mouse (closed circle) versus
LCMV-infected targets. Trian-
gles represent lysis by wild-type
(open triangle) and HY-transgenic
(closed triangle) mice against unin-
fected targets. 
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pCTL frequency per CD8 cell is within a factor of two of
that observed at the height of the acute infection (18, 19).
LDAs in one experiment showed that 240 d after LCMV
infection, 1 in 158 CD8
 
1
 
 spleen leukocytes in a C57BL/6
mouse were LCMV-specific, whereas in a HY-transgenic
mouse, only 1 in 1,598 CD8
 
1
 
 spleen leukocytes were
LCMV-specific 58 d after LCMV infection. In a second
experiment, the pCTL frequency in the C57BL/6 mouse
was 1 in 85 at 411 d after infection and 1 in 580 in the HY-
transgenic mouse at 118 d after LCMV. This 7–10-fold re-
duction in the number of pCTL is consistent with the less
vigorous CTL response that takes place during acute infection.
 
Specificity of CTLs Generated during LCMV Infection of
HY-transgenic Mice. 
 
To further characterize the CTL re-
sponse in the HY-transgenic animals, we analyzed the
specificity of the antiviral CTLs generated during acute in-
fection. We first sought to determine which of the three
well-defined LCMV immunodominant peptides, nucle-
oprotein (NP) 397 (20), glycoprotein (GP) 33 (21), or GP
278 (21), would sensitize target cells to lysis by CTLs gen-
erated in the HY-transgenic mouse during acute virus in-
fection. As seen in Fig. 2, spleen cells and FACS
 
Ò
 
-sorted
CD8 cells from HY animals showed a tendency to lyse
RMA-S cells coated with either of the immunodominant
LCMV peptides GP 33 (KAVYNFATCGIFA) or NP 397
(QPQNGQFIHFY). Wild-type C57BL/6 mice also gen-
erated CTLs that lysed targets coated with these two pep-
tides as well as cells coated with a third immunodominant
peptide GP 278 (VENPGGYCL), confirming studies by
Whitton et al. (21). None of the HY-transgenic mice
showed any lytic activity toward GP 278–coated targets,
but it is possible that GP 278–restricted CTLs may have
been generated at a frequency too low to detect in bulk as-
says. This pattern of lysis was consistent in four other ex-
periments, but one animal out of six did not exhibit any
NP 397–restricted CTL activity. These observations are in
general agreement with Doherty et al. (16) who showed,
upon LCMV infection of mice transgenic for a randomly
selected TCR, that CTLs were generated with an epitope
specificity that was similar to that of wild-type CBA/Ca
mice.
The generation of CTLs capable of killing not only vi-
rus-infected targets, but also uninfected allogeneic targets,
is a facet of acute LCMV infection (2). We thus performed
CTL assays to determine if the restricted TCR repertoire
in HY-transgenic mice precluded the generation of al-
lospecific CTLs during acute infection. Fig. 3 shows the
pattern of allogeneic target cell lysis exhibited by unsorted
cells and by FACS
 
Ò
 
-sorted CD8
 
1
 
 cells from HY animals
and unsorted effector cells from a C57BL/6 mouse. While
the C57BL/6 animal displayed lysis against both P815 (H-2
 
d
 
)
and L929 (H-2
 
k
 
) targets, the HY-transgenic animal exhib-
ited preferential lysis of targets expressing the H-2
 
k
 
 allo-
type. This pattern of CTL activity was consistent in six dif-
ferent experiments. In three of the six experiments, this H-2
 
k
 
killing in the HY mice was equal to or greater than the ob-
served lytic activity seen against LCMV-infected syngeneic
targets. The inability to generate an anti–H-2
 
d
 
 response was
not due to a specific lesion in the T cell repertoire because
HY-transgenic mice generated comparable levels of both
an anti–H-2k (58% specific lysis of L929 cells in a C57BL/6-
HY anti-C3H culture at 106 responders/well) as well as an
anti-H-2d (54% specific lysis of P815 cells in a C57BL/6-
HY anti-BALB/c culture at 106 responders/well) CTL re-
sponse in allogeneic mixed lymphocyte cultures in vitro.
This selective stimulation of H-2k, but not H-2d-specific
CTLs in the HY-transgenic mice during acute LCMV in-
fection, is consistent with the concept that the generation
Figure 2. Peptide specificity of CTLs generated 8 d after LCMV infec-
tion. Spleen cells were prepared as stated in Materials and Methods and
tested against 51Cr-labeled RMA-S cells pulsed overnight with 200 mM
of the various peptides. Pooled spleen cells from two HY-transgenic mice
were either unsorted or else sorted for CD81 cells, and were 96% pure.
Pooled spleen cells from two C57BL/6 mice were unsorted. Target cells
are as follows: RMA-S (open circle), RMA-S 1 GP 278 (open triangle),
RMA-S 1 NP 397 (closed triangle), and RMA-S 1 GP 33 (closed circle).
Figure 3. Allospecificity of CTLs generated 8 d after LCMV infection.
Spleen cells were prepared as stated in Materials and Methods and tested
against 51Cr-labeled targets. Pooled spleen cells from two HY-transgenic
mice were either unsorted or sorted for CD81 cells, and were 97% pure.
Pooled C57BL/6 spleen cells were unsorted. Target cells are as follows:
(open circle) MC57G (H-2b), (open triangle) P815 (H-2d), and (closed circle)
L929 (H-2k).1633 Zarozinski and Welsh
of allospecific CTL is antigen-driven and is not the conse-
quence of bystander activation.
Thus, it appears that the HY-transgenic mouse clears
LCMV more slowly than wild-type C57BL/6 mice (Table
1) and with diminished CTL diversity (Fig. 3) and less
vigor (Fig. 1).
Fate of HY-specific T Cells during LCMV Infection.  The
specificities of only 5–10% of the CD81 T cells generated
during acute LCMV infection can be accounted for by
LDAs and bulk CTL assays, and the driving force behind
this massive expansion, be it bystander stimulation or low
affinity cross-reactivity at the level of the TCR, has been
unclear. To clarify this point, we chose to examine the fate
of the HY-specific transgenic T cells during the course of
the acute LCMV infection. While all T cells in these ani-
mals have a single TCR-b chain, only about one-half to
one-third of the CD81 T cells also express the transgenic a
chain, which can be detected by the monoclonal antibody
T3.70. It is this dual expression of both chains that imparts
HY specificity upon that cell. If this population of cells en-
tered into blastogenesis and increased in number during vi-
ral infection, this would be consistent with bystander acti-
vation. However, if the HY-specific T cells remained small
in size and became diluted during the course of LCMV in-
fection, this would support the hypothesis that bystander
stimulation of naive T cells does not occur.
A representative experiment shown in Fig. 4 indicates
that the HY-specific cells did not undergo blastogenesis
during acute LCMV infection. At day 8 after infection, the
CD81/T3.701 cells (R1 gate) had a mean forward scatter
(FSC) of 434, whereas the CD81/T3.702 (R2 gate) cells
responded to the virus and had a much larger FSC mean of
530. A similar phenomenon was shown by examining the
side scatter, which is a measure of the granularity of the
two populations; the HY-transgenic cells had a mean SSC
of 99, whereas the other CD81 cells had a mean SSC of
197. This difference indicates that the HY-specific T cells
were smaller and of lower granularity than the other CD8
cells. Another indication that the HY-specific T cells were
not activated during this time is the fact that they expressed
higher levels of CD8 than did most of the remaining CD81
T cells (Fig. 4). Activated T cells induced during LCMV
infection express lower levels of CD8 (6).
The absolute numbers of the HY-specific T cells present
in the spleen were reduced in number by day 8. 18 uninfected
HY mice had an average of 4.2 6 1.1 3 106 HY-specific
cells per spleen; this number dropped in three experiments
representing six mice to 2.9 6 0.3 3 106 HY-specific T
cells by day 8 after infection. Concomitant with this reduc-
tion in HY-specific cells was an increase in the remaining
CD81 cells from 6.1 6 2.1 3 106 to 10.3 6 2.4 3 106 at day
8 after LCMV. Thus, there appeared to be a selection for
the responding HY-nonspecific CD81 cells entering into
blastogenesis, while those HY-specific cells remained small in
size and appeared to be diluted out as the immune response
progressed. These data argue in favor of the concept that
the profound stimulation seen during LCMV infection is
not a consequence of bystander activation of non–virus-
specific naive T cells present at the site of a vigorous immune
response.
Stimulation of HY-specific T Cells in Male Mice.  This lack
of stimulation of HY-specific T cells seen during viral in-
fection was not due to the fact that these HY-specific T
cells were incapable of responding to antigen because 4 d
after adoptive transfer of spleen cells from a female HY-
transgenic mouse into a male C57BL/6 mouse, the CD81/
T3.701 T cells entered into blastogenesis as indicated by an
increase in mean FSC from 488 to 624. This is in agree-
ment with Rocha and von Boehmer, who showed prolif-
eration of HY-specific T cells after transfer into male mice
(22).
HY-chimeric Mice.  The lack of bystander activation of
HY-specific cells seen during LCMV infection could have
been due to the requirement for TCR engagement needed
for T cells to proliferate, or it could have been due to the
fact that the antiviral immune response in the HY animals
was not as vigorous as that seen in wild-type mice, and
therefore was below the threshold required for inducing
bystander stimulation. To compensate for this, we created
an environment in which the HY-specific T cells would be
present in a milieu where a robust immune response mim-
icking that seen in the wild-type animal would take place.
This was done by creation of a HY normal mouse chimera.
HY-chimeric mice were HY-transgenic mice adoptively
reconstituted with 5 3 107 spleen cells from normal C57BL/6
female mice. This led to a T cell population that contained
the HY-specific T cells and the adoptively transferred T
cells that expressed a wide variety of TCRs. These adop-
tively transferred cells could respond to viral infection with
the intensity nearly equal to that of wild-type mice, thus
mimicking a normal host response to viral infection.
Figure 4. HY-specific T cells fail to enter into blastogenesis during acute
LCMV infection. A FACSÒ profile of spleen cells from an HY-transgenic
mouse stained with anti-CD8-PE, T3.70-biotin and streptavidin-FITC 8 d
after LCMV infection is shown on the right. Relative cell size as mea-
sured by FSC is shown on the left. The R1 gate shows the HY-specific
(T3.701/CD81) T cells and the R2 gate (T3.702/CD81) represents the
remaining CD8 cells.1634 Analysis of T Cell Bystander Activation
As can be seen in Fig. 5, in the environment of the HY-
chimeric mice, the HY-specific T cells (R1 gate) failed to
enter into blastogenesis 7 d after LCMV infection, even
though many of the remaining CD81 T cells increased in
both size and number. The HY-specific cells also remained
small in size at day 3, 5, 9, and 11 after infection (data not
shown). Here again, the HY-specific T cells expressed
higher levels of CD8 than did the other CD81 cells, pro-
viding further evidence for their lack of participation in this
antiviral response. We next examined the spleens of HY-
chimeric mice at day 3, 5, 7, 9, 11, and 31 and determined
the absolute number of HY-specific transgenic CD8 T cells
(CD81/T3.701) and the remaining (CD81/T3.702) CD8
T cells (Fig. 6). As expected, little expansion in the total
CD8 T cell number was seen until between day 7 and 9, at
which time there was nearly a threefold expansion in the
number of non–HY-specific CD81 T cells (closed bars).
Concomitant with this increase in CD81 T cells was a re-
duction in the number of HY-specific CD8 T cells (open
bars). This suggests that a nonresponding cell population
not entering into blastogenesis is diluted in the spleen by
those cells responding to viral antigen. This dilution, how-
ever, is not permanent. By day 31 after LCMV infection
and beyond, well after infectious virus was cleared, the HY
specific cells once again were detected in the spleen of HY-
chimeras. It is not clear whether these HY-specific T cells
found after virus infection represent those cells that were
forced out of the spleen during acute LCMV-infection or
whether they were recent thymic emigrates.
We next attempted to look for bystander activation of
memory cells by exposing spleen cells from HY-transgenic
mice to male antigen in vivo and determining their fate
during acute LCMV infection. This was accomplished us-
ing a method similar to Bruno et al. (23) by adoptive trans-
fer of 4 3 107 spleen cells from female HY-transgenic mice
into irradiated (C57BL/6 3 bm12)F1 male mice. The
(C57BL/6  3 bm12)F1 mice provide both the HY antigen
as well as allogeneic MHC class II molecules that can be
recognized by CD41 T cells that, in turn, provide T cell
help that promotes the survival of HY-specific memory
cells. After 10 d 3 3 107 (experiment 1) or 4 3 107 (exper-
iment 2) spleen cells from the reconstituted (C57BL/6 3
bm12)F1 male mice were then adoptively transferred into
irradiated (600 Rad) female a/b-TCR knockout C57BL/6
mice. At the time of transfer into the female mice, these
antigen-experienced, HY-specific T cells were larger than
naive cells, with FSC values of 520 to 551 (versus 417–425
for naive HY-specific CD81 cells) and comprised 90% (ex-
periment 1) to 82% (experiment 2) of all the CD81 T cells
in the spleen. 3–4 wk later, some of these recipient mice
were challenged with LCMV, and some recipients were
rendered chimeric with normal C57BL/6 splenocytes as in
Figs. 5 and 6 and then challenged with LCMV. The abso-
lute number of antigen-experienced HY-specific cells and
the remaining CD81 T cells per spleen were monitored,
and the CTL activity was examined 8 d after infection.
Very low levels of CTL activity were detected in nonchi-
meric animals (,1% specific lysis, n 5 4), whereas at an E/T
ratio of 100:1, specific lysis ranged from 9 to 41% in chi-
meric recipient mice (n 5 6).
In experiment 1, the number of antigen-experienced
HY-transgenic splenocytes in uninfected recipient (n 5 1),
LCMV-infected recipient (n 5 2), and LCMV-infected
chimeric recipient (n 5 4) mice averaged 6, 7.2, and ,2.5 3
105, respectively, with two of four chimeric recipient mice
having no detectable HY-transgenic cells. The remaining
Figure 5. HY-specific T cells fail to enter into blastogenesis during acute
LCMV infection even in HY-chimeric animals. A FACSÒ profile of
spleen cells from an HY-chimeric mouse 7 d after LCMV infection
stained with anti-CD8-RED613, T3.70-biotin, and streptavidin-FITC is
shown on the right. Relative cell size as measured by FSC is shown on
the left. The R1 gate shows the HY-specific (T3.701/CD81) T cells and
the R2 gate (T3.702/CD81) represents the remaining CD8 cells.
Figure 6. HY-specific T cells are diluted greatly during acute LCMV in-
fection in HY-chimeric animals. Spleen cells from HY-chimeric animals
were stained with anti-CD8-RED613, T3.70-biotin, and streptavidin-
FITC antibodies, and the absolute number of spleen cells was determined
for various days after LCMV infection: day 0, n 5 18; days 3, 5, 7, and 9,
n 5 5; day 11, n 5 2; immune (31–203 d), n 5 10. The open bars repre-
sent the transgenic CD81/T3.701 cells, while the filled bars represent the
non–HY-specific CD81/T3.702 cells.1635 Zarozinski and Welsh
CD81 cell number averaged 8, 11, and 34 3 105. In exper-
iment 2, the antigen-experienced HY splenocyte numbers
averaged 24 (n 5 1), 14 (n 5 2), and 8 3 105 (n 5 2) cells,
respectively, whereas the remaining CD81 splenocytes
numbers were 36, 25, and 140 3 105. This indicates that as
the nontransgenic CD81 T cells responded to the LCMV
infection and increased in number, the antigen-experienced
HY cells decreased in number much like they did in the
HY-chimeric mice in Fig. 6. These results indicate that
there was no significant bystander activation of these anti-
gen-experienced cells.
Lack of Bystander Activation in LCMV-carrier Mice.  Another
system was used to look for bystander activation of T cells
during an LCMV-specific immune response. This system
involved the adoptive transfer of spleen cells from an
LCMV-immune mouse into LCMV-carrier mice. LCMV-
carrier mice are persistently infected with LCMV due to
the fact that they have been infected in utero and have
clonally deleted LCMV-reactive T cells (24). King et al.
demonstrated that transfer of T cells from LCMV-immune
mice into persistently infected mice resulted in clearance of
infectious virus from the thymus by day 8 after transfer
(24). Using Thy1 congenic mice, it was possible to distin-
guish the immune donor T cells (CD81/Thy1.22) from
the host T cells (CD81/Thy1.21), and to observe if the ac-
tivation and proliferation of the immune donor cells re-
sulted in bystander activation of host T cells. This differs
from the HY-transgenic experiments in that the LCMV
carriers are housed conventionally and have both naive as
well as memory T cells as candidates for bystander activation.
6 d after adoptive transfer of Thy1.11 spleen cells from a
control mouse into Thy1.21 LCMV-carrier mice, few, if
any, donor CD81/Thy1.22 cells were found in the spleen
(Fig. 7). However, 6 d after adoptive transfer of spleen cells
from a Thy1.11 LCMV-immune mouse into a Thy1.21
LCMV-carrier mouse (Fig. 8), both donor Thy1.22 and
host Thy1.21 cells were observed in the spleen. Comparing
the relative cell size of these two populations, the host
Thy1.21 (R1 gate) cells appeared equal in size relative to
cells in the mouse that received naive Thy1.11 cells, whereas
the Thy1.22 donor cells derived from LCMV-immune
mice (R2 gate) were of large size and probably proliferating.
Table 2 provides a summary of three adoptive transfer ex-
periments. After transfer of LCMV-immune spleen cells
into the carrier mice, the donor CD8 cells had greater for-
ward scatter than did the host cells (P ,0.005). The num-
ber of host CD81 cells present in the spleen dropped con-
comitantly with an increase in the numbers of CD81
donor cells (Table 2). Thus, there was no demonstrable by-
stander proliferation of host cells in the context of this vig-
orous immune response.
The cell surface phenotype of the donor and host cells
was examined to look for any changes in activation mole-
cules that may have occurred in either the donor or host
cell populations. Fig. 9 shows the expression of MEL-14
(L-selectin) and CD44 on the donor and on the host CD81
cells 6 d after adoptive transfer of either naive Thy1.22 (na-
ive transfer) or LCMV-immune Thy1.22 spleen cells (im-
mune transfer). (Fig. 9, left) MEL-14 expression on host cells
remained at the same high levels regardless of whether na-
ive or immune spleen cells were transferred, whereas the
donor cell population consisted of mostly MEL-14low cells.
This demonstrates that the donor CD81 cells are activated
since MEL-14 expression is decreased on LCMV-induced
activated CD8 cells (5). (Fig. 9, right) The expression of
CD44 on the donor and host cells is shown. Donor cells
were predominantly CD44high, whereas host cells showed
little change in their moderate cell surface expression of
CD44. Table 2 summarizes the expression of MEL-14 and
CD44 in three adoptive transfer experiments. It can be
seen that the mean fluorescent intensity for MEL-14 and
CD44 on host CD81 cells changed little after adoptive
transfer of LCMV naive or immune spleen cells. However,
the donor CD81 cells expressed less MEL-14 (P ,0.009)
and higher levels of CD44 (P ,0.13), consistent with them
being activated cells. All data shown are from day 6 after
Figure 7. Inability to recover
Thy1.11 naive cells 6 d after
transfer into LCMV-carrier
mice. A FACSÒ profile of spleen
cells from an LCMV-carrier
Thy1.21 mouse, 6 d after intra-
venous adoptive transfer of 2 3
107 LCMV-naive Thy1.11 spleen
cells, stained with anti-CD8-
FITC and anti-Thy1.2-PE. The
histogram represents the relative
cell size as measured by FSC of
the CD81/Thy1.21 host cells.
Figure 8. LCMV-carrier host CD81 cells do not enter into blastogenesis
after transfer of LCMV-immune donor spleen cells. A FACSÒ profile of
spleen cells from an LCMV-carrier-Thy1.21 mouse 6 d after intravenous
adoptive transfer of 2 3 107 LCMV-immune Thy1.1 spleen cells stained
with anti-CD8-FITC and anti-Thy1.2-PE. The histograms represent the
relative cell size as measured by FSC of the CD81/Thy1.21 host cells (R1
gate) and the transferred donor cells CD81/Thy1.22 (R2 gate).1636 Analysis of T Cell Bystander Activation
adoptive transfer, which was the peak of the donor cell re-
sponse. LCMV-carrier mice were also examined on days 5,
7, and 8 after adoptive transfer. At none of these days was
there any indication of an increase in number, size, or
change in cell surface markers (MEL-14 and CD44) in the
host CD8 cells. It should be pointed out that there was no
increase in the frequency of the population of host cells that
express the memory antigenic phenotype (CD44hi), nor
was their any increase in their cell size as measured by FSC.
It has recently been suggested that IFN may be a non-
specific polyclonal stimulator of memory CD8 T cells (25).
One distinction between the immune response engendered
by adoptive transfer of T cells into the LCMV-carrier mice
and that occurring during an acute LCMV infection is that
high levels of IFN-a/b are generated during the acute in-
fection. To mimic this induction, the carriers were given
the IFN-a/b inducer poly inosinic:cytidylic acid (poly I:C),
which we have previously shown induces IFN and NK cell
proliferation in normal and LCMV-carrier mice (26). The
poly I:C treatment with or without immune cell transfer
did not increase the number or size of host cells, nor did it
reduce host MEL-14 expression or raise host CD44 expres-
sion, which are associated with CD8 cell activation. The
only noticeable effect of poly I:C treatment was that it
slightly reduced the total number of spleen cells from 1.0 6
0.2 3 108 in untreated mice to 8.7 6 0.7 3 107 in animals
that received poly I:C and LCMV-immune spleen cells.
Poly I:C treatment reduced the absolute number of host
CD81 cells, while not dramatically affecting the number of
donor CD81 cells, and in one experiment, slightly de-
creased, rather than increased, CD44 expression on host
CD8 cells. The reduction in the number of host CD8 cells
indicated that this regimen of poly I:C was functioning in
vivo, and we confirmed in parallel experiments that the
carrier mice synthesized IFN in response to the poly I:C
treatment.
To show that LCMV-carrier host spleen cells could in-
deed undergo blastogenesis, these mice were infected with
5 3 106 PFU of PV and examined for T cell activation 8 d
later. In two separate experiments involving five mice, the
Table 2. Effects of Immune Cell Transfer in LCMV-carrier Mice
Treatment* n CD8 Cell No. 3 106 Mean FSC CD44 MFI‡ MEL-14 MFI
Experiment No. 1 (2 3 107 cells transfered)
Host (naive transfer) 1 15 642 ND ND
Host (immune transfer) 3 12 6 3 639 6 3N D N D
Donor (immune transfer) 3 5.3 6 2 717 6 11 ND ND
Experiment No. 2 (4 3 107 cells transferred§)
Host (naive transfer) 2 12 6 2 563 6 5 760 6 24 449 6 19
Host (immune transfer) 3 6.1 6 1 578 6 8 723 6 85 433 6 12
Donor (immune transfer) 3 4.5 6 1 726 6 4 846 6 54i 318 6 5
Host 1 poly I:C (naive transfer) 2 10 6 1 578 6 1 749 6 2 435 6 7
Host 1 poly I:C (immune transfer) 3 4.0 6 0.6 565 6 18 783 6 74 423 6 12
Donor 1 poly I:C (immune transfer) 3 4.0 6 0.6 720 6 23 885 6 6 316 6 7
Experiment No. 3 (3 3 107 cells transferred§)
Host (naive transfer) 2 7.8 6 1 498 6 13 533 6 18 479 6 7
Host (immune transfer) 4 4.9 6 0.7 494 6 7 512 6 11 505 6 30
Donor (immune transfer) 4 3.7 6 0.8 630 6 7 698 6 15 385 6 21
Host 1 poly I:C (naive transfer) 2 7.0 6 2 496 6 16 505 6 16 485 6 6
Host 1 poly I:C (immune transfer) 3 3.8 6 0.6 471 6 11 447 6 22¶ 457 6 19
Donor 1 poly I:C (immune transfer) 3 3.8 6 0.7 627 6 21 666 6 22 350 6 27
*LCMV-carrier mice received the indicated number of either LCMV-immune (immune transfer) or naive spleen cells (naive transfer) as detailed in Ma-
terials and Methods. They were then either left untreated or treated with 100 mg poly I:C intraperitoneally after transfer. 6 d after adoptive transfer,
the spleens were harvested and stained as stated in the text.
‡MFI, mean fluorescent intensity.
§The differences between the mean FCS and MEL-14 MFI of host (naive transfer) and donor cells are all significant at P ,0.005 for FSC and
P ,0.009 for MEL-14, as determined by Student’s t test.
iDifferent (P ,0.13) from host (naive transfer).
¶Different from both host (naive transfer) (P ,0.02) and host 1 poly I:C (naive transfer) (P ,0.05).1637 Zarozinski and Welsh
mean FSC of the CD8 cells increased an average of 58 6 5,
whereas the mean fluorescent intensity of MEL-14 dropped
by 45 6 12 and the mean fluorescent intensity of CD44 in-
creased by 22 6 13. This indicates that the CD8 cells in the
LCMV-carrier mice become activated in response to infec-
tious agents to which they are not tolerant.
Discussion
In this study we have provided evidence that the massive
expansion in CD8 T cells during an acute LCMV infection
can not be accounted for simply by bystander activation
and therefore must involve TCR-specific recognition.
Many viruses, such as VV, MCMV, PV (3), and EBV (27)
can generate CTLs capable of lysing MHC-mismatched
cells upon infection, arguing in favor of a general, nonspe-
cific induction of allospecific T cells during viral infection
(3). Yet, CTL clones cross-reactive between uninfected al-
logeneic targets and virus-infected syngeneic targets have
been observed in several systems (3) and the allospecific
CTLs induced during LCMV infection can be propagated
on LCMV-infected syngeneic APC stimulators, providing
evidence for a cross-reactive TCR-specific mechanism (1).
Those results did not, however, rule out the possibility that
a component of the allospecific CTL stimulation, as well as
the stimulation of the majority of the T cells whose speci-
ficity was unknown, could be due to a nonspecific by-
stander activation. The results provided here indicate that
bystander stimulation does not account for this expansion
of T cell number. This conclusion is based on the observa-
tions that only one of two potential allospecific CTL speci-
ficities are induced by LCMV infection in a milieu with a
restricted CTL repertoire (Fig. 3), that the activation and
proliferation of transgenic T cells not specific for LCMV
are not induced in the wake of a vigorous T cell response
(Fig. 6), and that the induction of an active T cell response
in an immunologically tolerant host fails to activate and ex-
pand the host T cells (Figs. 8 and 9).
We chose to examine the HY-specific T cell as one par-
ticular T cell with a clonotypic TCR not cross-reactive
with LCMV to observe its fate during the course of viral
infection. Our results show that such HY-specific T cells
failed to enter into blastogenesis during acute infection of
HY-transgenic mice or even in the HY-chimeric animals,
which mounted more vigorous responses to LCMV than
did the HY-transgenic animals. In fact, the nonresponding
HY-transgenic cells were diluted in number during the
course of an LCMV infection, even though much prolifer-
ation was found in the nontransgenic T cells. The fact that
the HY-specific T cells do return to normal numbers after
viral clearance may indicate that as T cells are removed
from the spleen by apoptosis during the terminal phase of
the acute response (28), naive cells repopulate the spleen so
that they can respond to future infectious agents. Using the
LCMV-carrier mice we showed that, while the adoptively
transferred immune cells expressed an activation and blasto-
genesis phenotype, the host cells, much like the HY-trans-
genic cells, remained small in size and nonactivated (Figs. 8
and 9). In the LCMV-carrier system, the nonresponding
host cells represent a diverse T cell population containing
memory cells and T cells with a wider diversity of TCR
specificities than do the HY-transgenic T cells.
Figure 9. CD44 and MEL-14
expression on donor or LCMV-
carrier host cells after transfer of
LCMV-immune Thy1.11 spleen
cells. FACSÒ profiles of spleen
cells from an LCMV-carrier
mouse 6 d after intravenous
adoptive transfer of 3 3 107
LCMV-naive Thy1.1 spleen (na-
ive transfer) or 3 3 107 LCMV-
immune Thy1.1 spleen cells (im-
mune transfer). Cells were
stained with anti-CD8-FITC,
anti-Thy1.2-PE, and anti-CD44-
biotin, or anti-Thy1.2-biotin
and anti-MEL-14-FITC. The
histograms represent the relative
fluorescent intensity of the
CD81/Thy1.21 host cells and
the transferred donor cells
CD81/Thy1.22.1638 Analysis of T Cell Bystander Activation
An explanation for this lack of proliferation among the
HY-specific cells and the LCMV-carrier T cells may be
that these cells are not stimulated via the TCR and there-
fore do not receive the proper intracellular signals that are
required for a productive T cell response, regardless of the
diversity and concentration of cytokines present. If this as-
sumption is correct, then it is likely that those T cells that
become activated during acute LCMV infection are indeed
LCMV-specific at some level and have TCRs that have
some affinity for LCMV-peptide–MHC complexes. The
observation that upon LCMV infection of HY-transgenic
mice, CTL lysed H-2k but not H-2d allogeneic targets even
though these mice have pCTL to H-2d, indicates that this
is not an indiscriminate bystander activation response. Here
the restrictions of the limited TCR repertoire apparently
precluded the generation of CTLs cross-reactive between
H-2d and virus-modified H-2b.
It has recently been suggested that IFN induced during
virus infections may contribute to a bystander stimulation
of memory CD8 cells (25). Memory cells have a wider di-
versity of cytokine receptors and adhesion molecules on
their surfaces than do naive cells, and their activation is
much less dependent upon costimulatory molecules (29).
Experiments have, in fact, demonstrated that infections of
LCMV-immune mice with serologically unrelated viruses,
such as VV, PV, or MCMV can indeed reactivate LCMV-
specific memory cells easily detectable in bulk cultures (3,
10). However, analyses of CTL clones isolated from LCMV-
immune mice infected with PV or VV have revealed
clones with dual specificity, cross-reactive between the two
viruses. This argues that even the activation and expansion
of putatively unrelated memory CTLs may involve some
level of cross-reactivity and may not simply be by bystander
activation. Our studies with the LCMV-carrier mice, which
were kept in a conventional environment and should have
memory cells specific for environmental antigens, support
the concept that any bystander activation of memory cells
contributes little to the T cell expansion seen during acute
LCMV infection. The injection of poly I:C to induce
higher levels of IFN in the recipient carrier mice also did
not increase the size or number of the host cells. It should
be noted that during the acute infection, the peak in T cell
proliferation parallels the levels of IL-2 and comes several
days after the peak in type I IFN (30). Taken together, the
data presented here support the notion that bystander acti-
vation of T cells not specific for the virus contributes little
to the polyclonal T cell response to LCMV infection, indi-
cating that antigen recognition at the level of the TCR
must be the decisive event.
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